Tower Research Capital (TRC)’s PolyPid PYPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-72
Closed -$10K 6400
2022
Q2
$10K Buy
72
+38
+112% +$5.69K ﹤0.01% 4475
2022
Q1
$6K Buy
+34
New +$5.15K ﹤0.01% 4916
2021
Q3
Sell
-11
Closed -$3K 6086
2021
Q2
$3K Sell
11
-67
-86% -$18.6K ﹤0.01% 4946
2021
Q1
$22K Buy
78
+18
+30% +$5.87K ﹤0.01% 3816
2020
Q4
$18K Buy
+60
New +$19.1K ﹤0.01% 3937

Other funds holding PYPD

Tower Research Capital (TRC)'s PYPD Position: Q3 2022 in Review

Tower Research Capital (TRC) sold out of PolyPid (PYPD) in Q3 2022, closing a stake of 72 shares — an estimated $10K sold.

Tower Research Capital (TRC) first reported a position in PYPD in Q4 2020 and held it in 5 quarters. The position peaked at $22K in Q1 2021. 17 funds tracked by Wall St. Rank hold PYPD as of Q3 2022.

  • Tower Research Capital (TRC) reported no remaining PolyPid position as of Q3 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 72 PolyPid shares in Q3 2022, an estimated $10K.
  • Tower Research Capital (TRC) first reported a position in PolyPid in Q4 2020 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s PolyPid position peaked at $22K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held PolyPid as of Q3 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.